Positive Sentiment Still Eludes ScanSource, Inc. (NASDAQ:SCSC) Following 26% Share Price Slump

ScanSource, Inc. (NASDAQ:SCSC) shareholders that were waiting for something to happen have been dealt a blow with a 26% share price drop in the last month. Instead of being rewarded, shareholders who have already held through the last twelve months are now sitting on a 11% share price drop.

After such a large drop in price, given about half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may consider ScanSource as an attractive investment with its 14x P/E ratio. However, the P/E might be low for a reason and it requires further investigation to determine if it's justified.

While the market has experienced earnings growth lately, ScanSource's earnings have gone into reverse gear, which is not great. It seems that many are expecting the dour earnings performance to persist, which has repressed the P/E. If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.

See our latest analysis for ScanSource

pe-multiple-vs-industry
NasdaqGS:SCSC Price to Earnings Ratio vs Industry February 16th 2025
If you'd like to see what analysts are forecasting going forward, you should check out our free report on ScanSource.
Advertisement

Is There Any Growth For ScanSource?

There's an inherent assumption that a company should underperform the market for P/E ratios like ScanSource's to be considered reasonable.

If we review the last year of earnings, dishearteningly the company's profits fell to the tune of 25%. As a result, earnings from three years ago have also fallen 14% overall. Accordingly, shareholders would have felt downbeat about the medium-term rates of earnings growth.

Turning to the outlook, the next year should generate growth of 18% as estimated by the three analysts watching the company. That's shaping up to be materially higher than the 15% growth forecast for the broader market.

With this information, we find it odd that ScanSource is trading at a P/E lower than the market. Apparently some shareholders are doubtful of the forecasts and have been accepting significantly lower selling prices.

The Final Word

ScanSource's recently weak share price has pulled its P/E below most other companies. Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.

Our examination of ScanSource's analyst forecasts revealed that its superior earnings outlook isn't contributing to its P/E anywhere near as much as we would have predicted. When we see a strong earnings outlook with faster-than-market growth, we assume potential risks are what might be placing significant pressure on the P/E ratio. At least price risks look to be very low, but investors seem to think future earnings could see a lot of volatility.

Don't forget that there may be other risks. For instance, we've identified 1 warning sign for ScanSource that you should be aware of.

If you're unsure about the strength of ScanSource's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

M
mitchell_lawler
mitchell_lawler

When oil spikes, crude gets the attention. I think the boring refiner in the middle is where it gets interesting, and a record shows why.

56
Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
85

About NasdaqGS:SCSC

ScanSource

Engages in the distribution of technology products and solutions in the United States, Brazil, and internationally.

Flawless balance sheet and good value.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.576.0% undervalued
49 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
AN
andrei9868
Emerging Author
NOW logo
andrei9868 on ServiceNow ·

The Platform Turning Enterprise Chaos into Autonomous Workflows

Fair Value:US$17015.9% undervalued
29 users have followed this narrative
2 users have commented on this narrative
5 users have liked this narrative
JO
John_Eric
Emerging Author
VST logo
John_Eric on Vistra ·

Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here's the $472 Million Reason They Disagree.

Fair Value:US$291.8752.7% undervalued
16 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative
HA
HarishPK
Emerging Author
EVER logo
HarishPK on EverQuote ·

EverQuote and an Asymmetric Investment Opportunity

Fair Value:US$36.0931.2% undervalued
6 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

EP
SKP logo
Epstein_Research on StrikePoint Gold ·

Strikepoint Gold, massive M&A with Newmont!

Fair Value:CA$0.458.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BA
VINO logo
Bambrook_Investments on Virgin Wines UK ·

Virgin Wines UK aims for a sparkling revenue growth

Fair Value:UK£0.5755.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
3101 logo
AstrisCorporateAdvisory on Toyobo ·

AI-related MLCC films driving earnings momentum

Fair Value:JP¥1.5k11.8% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
375 users have followed this narrative
9 users have commented on this narrative
17 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.2% undervalued
128 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9119.3% overvalued
220 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Trending Discussion